Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 1.38 -1.43% -0.02
MRNS closed down 1.43 percent on Wednesday, October 16, 2019, on 33 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MRNS trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish -1.43%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.43%
Narrow Range Bar Range Contraction -1.43%
Stochastic Reached Oversold Weakness -1.43%
Inside Day Range Contraction -1.43%
Oversold Stochastic Weakness -1.43%
50 DMA Support Bullish -0.72%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.72%

Older signals for MRNS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
MRNS Chart by TradingView
Basic chart:
Profile
Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Chemistry Physical Sciences Drugs Alcohols Ketones Pregnanes Sedatives Neurosteroids
Is MRNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 16 The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
Oct 13 The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Sep 29 The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear
Sep 27 A Look At Benzinga Pro's Most-Searched Tickers For September 27, 2019
Sep 27 21 Healthcare Stocks Moving In Friday's Pre-Market Session
Sep 26 A Look At Benzinga Pro's Most-Searched Tickers For September 26, 2019
Sep 26 Mid-Afternoon Market Update: Crude Oil Down 1%; Marinus Pharmaceuticals Shares Spike Higher
Sep 26 BYND, ENTA and PSO among midday movers
Sep 26 Mid-Day Market Update: Rite Aid Surges On Earnings Beat; BioXcel Therapeutics Shares Slide
Sep 26 Marinus Shares Rip Higher On Positive Ganaxolone Midstage Data In Epileptic Seizures
See more MRNS news...
Indicators
Indicator Value
52 Week High 6.27
52 Week Low 0.77
Average Volume 1,529,338
200-Day Moving Average 3.1978
50-Day Moving Average 1.3906
20-Day Moving Average 1.4305
10-Day Moving Average 1.417
Average True Range 0.1337
ADX 20.2
+DI 26.0263
-DI 20.1518
Chandelier Exit (Long, 3 ATRs ) 1.5989
Chandelier Exit (Short, 3 ATRs ) 1.6611
Upper Bollinger Band 1.5945
Lower Bollinger Band 1.2665
Percent B (%b) 0.35
BandWidth 22.929046
MACD Line -0.0402
MACD Signal Line -0.0376
MACD Histogram -0.0027
Fundamentals Value
Market Cap 35.98 Million
Num Shares 26.1 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -1.25
Price-to-Sales 0.00
Price-to-Book 7.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.49
Resistance 3 (R3) 1.49 1.45 1.47
Resistance 2 (R2) 1.45 1.43 1.45 1.46
Resistance 1 (R1) 1.42 1.41 1.40 1.42 1.46
Pivot Point 1.38 1.38 1.38 1.38 1.38
Support 1 (S1) 1.35 1.36 1.33 1.35 1.30
Support 2 (S2) 1.31 1.34 1.31 1.30
Support 3 (S3) 1.28 1.31 1.29
Support 4 (S4) 1.28